T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling.
published in: Clinical Cancer Research
date of publication: 2017-12-07
language: English
main subject: follicular lymphoma
Cites articles 65
- 2014-09-01
Date
Title
Article - wd:Q47271511